Search results
Results From The WOW.Com Content Network
Numerous clinical trials have been performed to assess the use of dopamine agonists for the treatment of restless legs syndrome (RLS). RLS is identified by the strong urge to move and is a dopamine-dependent disorder. RLS symptoms decrease with the use of drugs that stimulate dopamine receptors and increase dopamine levels, such as dopamine ...
Dopamine receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS) and are implicated in many neurological processes, including motivational and incentive salience, cognition, memory, learning, and fine motor control, as well as modulation of neuroendocrine signaling.
These agents stimulate dopamine receptors. In doing so, they alleviate the symptoms associated with Parkinson's disease . Wikimedia Commons has media related to Dopamine agonists .
This is a list of investigational autism and pervasive developmental disorder drugs, ... – dopamine D 2 and D 3 receptor partial agonist, serotonin 5-HT 1A ...
Dopamine receptor agonists can be divided into non-selective dopamine receptor agonists, D 1-like receptor agonists, and D 2-like receptor agonists. Non-selective dopamine receptor agonists include dopamine, deoxyepinephrine (epinine), dinoxyline, and dopexamine. They are mostly peripherally selective drugs, are often also adrenergic receptor ...
The primary endogenous agonists of the sympathetic nervous system are the catecholamines (i.e., epinephrine [adrenaline], norepinephrine [noradrenaline], and dopamine), which function as both neurotransmitters and hormones. Sympathomimetic drugs are used to treat cardiac arrest and low blood pressure, or even delay premature labor, among other ...
Lisuride – an antiparkinson dopamine agonist of the ergoline class, that is also a dual 5-HT 2A / 5-HT 2C agonist [69] and 5-HT 2B antagonist. [70] Mefloquine – an antimalarial drug, also produces psychiatric side effects which may be mediated through 5-HT 2A and/or 5-HT 2C receptors. [71]
The drug should not be combined with other ergot derivatives. Dopamine antagonists such as antipsychotics and metoclopramide counteract some effects of cabergoline. The use of antihypertensive drugs should be intensively monitored because excessive hypotension may result from the combination.